The UK medicines authority has approved the use of the corona vaccine developed by British pharmaceutical company AstraZeneca and the University of Oxford,
The British government has ordered 100 million doses from the producer and will therefore be able to expand the vaccination program considerably.
The Netherlands also has an option for nearly twelve million doses.
Together, the European member states have an option for about four hundred million doses.
However, European countries are still awaiting approval of the vaccine by the European Medicines Agency (EMA).
This approval could take a few more weeks, deputy director Noël Wathion of EMA told the Belgian newspaper
Het Nieuwsblad on
"The data we have at the moment is not even enough to give the AstraZeneca vaccine a conditional authorization," said Wathion.